Geoff Harris
@seageoff
Venture Capitalist, Musician, Sounders and Patriots Fan. Recovering Bostonian.
ID: 4149242534
http://www.flyingfish.vc 06-11-2015 19:33:28
255 Tweet
467 Takipçi
261 Takip Edilen
Holy shit. This A.I calendar thing is sooo fucking good. My workaholic brain lacked alot of structure. Now I have it. Syncs with my calendly and google calendar so freaking good. OMG so much love. 🥰 Reclaim.ai from Dropbox reclaim.ai
Meet us at Web Summit! We're delighted to announce our Co-Founders Daniel Cintra saurav and Jordan Ritter will be “where the future goes to be born” this November. Jordan will be speaking on Centre Stage and Growth Summit. If you see us, ask for your early access 😉 #WebSummit
Couldn't be more excited to introduce our private beta of Scheduling Links from the amazing Reclaim.ai from Dropbox team. Scheduling links (or booking links) have been reinvented dozens of times now. But we're bringing something entirely new to the table. 🧵 bizjournals.com/portland/inno/…
We're here! In minutes, as part of Breakout Startups, we'll be talking about the future of productivity to the whole audience at Centre Stage Web Summit ! #WebSummit
So excited to be working with Ryan Fink and Ty Frackiewicz again. Loved the journey the first time around and excited for what's to come for digs Digs is a Figma-like collaboration tool for home builders and suppliers tcrn.ch/3wPpk1I via TechCrunch
Clarity raises $16M to fight deepfakes through detection tcrn.ch/49cXUV5 via TechCrunch The world needs this desperately and I'm happy to be supporting this amazing team in a small way
From the earliest meetings in the now defunct WeWork in Portland, it was clear that Henry Shapiro and Patrick Lightbody were engineers of the highest caliber and even better people. I'm very happy for the entire team to be able to take the next step in the journey by joining Dropbox
Latent Labs comes out of stealth today with $50M funding. Our goal? To push the frontiers of generative biology, giving partners instant access to tools capable of accelerating drug design. Every biotech or pharma company searching for the best therapeutic molecules understands